Jeon EK - Search Results

1

Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer.

Sun DS, Jeon EK, Won HS, Park JC, Shim BY, Park SY, Hong YS, Kim HK, Ko YH. Sun DS, et al. Among authors: jeon ek. Gastric Cancer. 2015 Jul;18(3):644-52. doi: 10.1007/s10120-014-0405-8. Epub 2014 Aug 7. Gastric Cancer. 2015. PMID: 25098925

2

Treatment outcomes of systemic chemotherapy for peritoneal carcinomatosis arising from gastric cancer with no measurable disease: retrospective analysis from a single center.

Hong SH, Shin YR, Roh SY, Jeon EK, Song KY, Park CH, Jeon HM, Hong YS. Hong SH, et al. Among authors: jeon ek, jeon hm. Gastric Cancer. 2013 Jul;16(3):290-300. doi: 10.1007/s10120-012-0182-1. Epub 2012 Aug 17. Gastric Cancer. 2013. PMID: 22898806

3

Pancreatic endocrine tumors: a report on a patient treated with sorafenib.

Jeong HK, Roh SY, Hong SH, Won HS, Jeon EK, Shin OR, Lee SL, Ko YH. Jeong HK, et al. Among authors: jeon ek. J Korean Med Sci. 2011 Jul;26(7):954-8. doi: 10.3346/jkms.2011.26.7.954. Epub 2011 Jun 20. J Korean Med Sci. 2011. PMID: 21738352 Free PMC article.

4

Prognostic significance of CD44s expression in resected non-small cell lung cancer.

Ko YH, Won HS, Jeon EK, Hong SH, Roh SY, Hong YS, Byun JH, Jung CK, Kang JH. Ko YH, et al. Among authors: jeon ek. BMC Cancer. 2011 Aug 7;11:340. doi: 10.1186/1471-2407-11-340. BMC Cancer. 2011. PMID: 21819617 Free PMC article.

5

Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer.

Jeon EK, Hong SH, Kim TH, Jung SE, Park JC, Won HS, Ko YH, Rho SY, Hong YS. Jeon EK, et al. Cancer Res Treat. 2011 Sep;43(3):148-53. doi: 10.4143/crt.2011.43.3.148. Epub 2011 Sep 30. Cancer Res Treat. 2011. PMID: 22022291 Free PMC article.

6

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats.

Lee JS, Kim YT, Jeon EK, Won HS, Cho YS, Ko YH. Lee JS, et al. Among authors: jeon ek. BMC Complement Altern Med. 2012 Aug 15;12:124. doi: 10.1186/1472-6882-12-124. BMC Complement Altern Med. 2012. PMID: 22894541 Free PMC article.

7

Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer.

Won HS, Kim YA, Lee JS, Jeon EK, An HJ, Sun DS, Ko YH, Kim JS. Won HS, et al. Among authors: jeon ek. Cancer Invest. 2013 Oct;31(8):516-21. doi: 10.3109/07357907.2013.826239. Epub 2013 Jul 31. Cancer Invest. 2013. PMID: 23902164

8

Human papillomavirus-stratified analysis of the prognostic role of miR-21 in oral cavity and oropharyngeal squamous cell carcinoma.

Ko YH, Won HS, Sun DS, An HJ, Jeon EK, Kim MS, Lee HH, Kang JH, Jung CK. Ko YH, et al. Among authors: jeon ek. Pathol Int. 2014 Oct;64(10):499-507. doi: 10.1111/pin.12201. Epub 2014 Sep 19. Pathol Int. 2014. PMID: 25236707

9

Clinical outcome of induction chemotherapy in locally advanced head and neck squamous cell carcinoma.

Won HS, Lee YS, Jeon EK, Hong SH, Kang JH, Kim YS, Yoo le R, Sun DI, Kim MS. Won HS, et al. Among authors: jeon ek. Anticancer Res. 2014 Oct;34(10):5709-14. Anticancer Res. 2014. PMID: 25275078

10

Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.

Ko YH, Roh SY, Won HS, Jeon EK, Hong SH, Lee MA, Kang JH, Hong YS, Kim MS, Jung CK. Ko YH, et al. Among authors: jeon ek. Head Neck Oncol. 2010 Oct 30;2:30. doi: 10.1186/1758-3284-2-30. Head Neck Oncol. 2010. PMID: 21034499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters